 |
 |
 |
 |
H.E.F. Inc.
Box 651 • Scarsdale, NY 10583 |
 |
 |
 |
 |
|
 |
|
|
 |
|
|
 |
|
|
 |
 |
 |
RELATED LINKS
Get the FREE Adobe Reader:
|
 |
 |
 |
 |
|
 |
|
|
 |
| |
|
|
 |
 |
he following articles have recently been published in various publications.
Downloads are available in Adobe Acrobat format:
|
 |
| ORIGINAL PAPERS |
 |
|
|
 |
| EDITORIALS |
 |
|
|
Symposium on Economic Challenges in Health Care: Can We Maintain Professionalism in an Atmosphere of Systems and Business?
Marvin Moser, MD- Am J Med Sci(2009) 337(6):394–395
|
|
|
|
Commentary on the management of elevated blood pressure hypertension in pregnancy
Marvin Moser, MD - J Clin Hypertens(2009) 11(5):289–291
|
|
|
|
Physician or clinical inertia: What is it? Is it really a problem? And what can be done about it?
Marvin Moser, MD - J Clin Hypertens(2009) 11(1):1–4
|
|
|
|
Bed rest first for hypertensive urgencies?
Marvin Moser, MD - J Clin Hypertens(2008) 10(9):661
|
|
|
|
Ten Years and Counting: The Journal of Clinical Hypertension
Marvin Moser, MD- J Clin Hypertens(2007) 10;5:333–340
|
|
|
|
Seven Decades of Progress
Marvin Moser, MD- J Clin Hypertens(2007) 9;5:310–313
|
|
|
|
Hypertension Treatment Guidelines: Is It Time for an Update?
Marvin Moser, MD- J Clin Hypertens(2007) 9;1:9–14
|
|
|
|
Hypertension Treatment–A Success Study
Marvin Moser, MD- J Clin Hypertens(2006) 8;5:313–314
|
|
|
|
More Confusing Messages From the Hypertension Treatment Trials
Marvin Moser, MD- J Clin Hypertens(2006) 8;1:8–11
|
|
|
|
Comments on the Present Status and Future Directions of Postgraduate Medical Education
Marvin Moser, MD- J Clin Hypertens(2005) 7;10:576–577
|
|
|
|
Comments on Progress, Medical Care, and the Overuse of Technology
Marvin Moser, MD- J Clin Hypertens(2005) 7;8:442–444
|
|
|
|
Are Lifestyle Interventions in the Management of Hypertension Effective? How Long Should You Wait Before Starting Specific Medical Therapy? An Ongoing Debate
Marvin Moser, MD- J Clin Hypertens(2005) 7;6:324–326
|
|
|
|
ROUNDTABLE DISCUSSIONS
|
|
|
|
Hypertension: Truly resistant or just difficult to control?
Kaplan N, Moser M. - The Medical Roundtable 2010:1(3):2001–2006
|
|
|
|
GPP2: Good publication practices for sponsored medical research: Elevating the integrity of scientific communications
Moser M, McMurray B, Sanes-Miller C, Yarker Y. - The Medical Roundtable 2010:1(2):120–127
|
|
|
|
What do the new trials tell us about the management of hypertension?
Moser M, Basile J, Cushman WC, Kaplan N. - The Medical Roundtable 2010;1(1):54–60
|
|
|
|
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers: Is There a Difference in Response and Any Advantage to Using Them Together in the Treatment of Hypertension?
Marvin Moser, MD; Clive Rosendorff, MD, PhD; William B. White, MD - J Clin Hypertens(2008) 10;6:489–496
|
|
|
|
How to Treat Hypertension in Patients With Coronary Heart Disease
Marvin Moser, MD; Jackson T. Wright Jr, MD, PhD; Ronald G. Victor, MD; Joel Handler, MD - J Clin Hypertens(2008) 10;5:390–397
|
|
|
|
The Treatment of Hypertension in the Elderly
Marvin Moser, MD; William C. Cushman, MD; Michael G. Ziegler, MD- J Clin Hypertens(2008) 10;1:58–68
|
|
|
|
Control of Blood Pressure: Does It Matter Which Agent You Use?
Marvin Moser, MD; William C. Cushman, MD; Norman M. Kaplan, MD- J Clin Hypertens(2007) 9;12:964–973
|
|
|
|
Microalbuminuria, Chronic Renal Disease, and the Effects of the Metabolic Syndrome on Cardiovascular Events
Marvin Moser, MD; James R. Sowers, MD; Henry R. Black, MD- J Clin Hypertens(2007) 9;7:551–556
|
|
|
|
The ALLHAT Study Revisited: Do Newer Data From This Trial and Others Indicate Changes in Treatment Guidelines?
Marvin Moser, MD; Suzanne Oparil, MD; William Cushman, MD; Vasilios Papademetriou, MD- J Clin Hypertens(2007) 9;5:372–380
|
|
|
|
The Nonpharmacologic Treatment of Hypertension: How Effective Is It? An Update
Marvin Moser, MD; Stanley S. Frankiln, MD; Joel Handler, MD- J Clin Hypertens(2007) 9;3:209–216
|
|
|
|
Prehypertension—What Is It and Should It Be Treated?
Marvin Moser, MD; Thomas D. Giles, MD; Thomas G. Pickering, MD, DPhil; Joseph L. Izzo, Jr., MD; Henry R. Black, MD- J Clin Hypertens(2006) 8;11:812–818
|
|
|
|
The ASCOT Trial—Are β-Blockers Still Useful as Antihypertensive Medication?
Marvin Moser, MD; Thomas D. Giles, MD; Thomas G. Pickering, MD, DPhil; Ronald G. Victor, MD- J Clin Hypertens(2006) 8;10:723–728
|
|
|
|
Resistant or Difficult-to-Treat Hypertension
Marvin Moser, MD; William Cushman, MD; Joel Handler, MD- J Clin Hypertens(2006) 8;6:434–440
|
|
|
|
Hypertensive Emergencies
Marvin Moser, MD; Joseph L. Izzo, Jr., MD; John Bisognano, MD- J Clin Hypertens(2006) 8;4:275–281
|
|
|
|
Out-of-Office Blood Pressures–Are They Helpful in Guiding the Treatment of Hypertension Patients?
Marvin Moser, MD; Raymond Townsend, MD; Norman Kaplan, MD- J Clin Hypertens(2006) 8;3:202–206
|
|
|
|
The Metabolic Syndrome–What Is It and How Should It Be Managed?
Marvin Moser, MD; Bonita Falkner, MD; Michael A. Weber, MD; Leonard Mark Keilson, MD- J Clin Hypertens(2006) 8;1:44–49
|
|
|
|
A Conversation With Drs. Kaplan and Moser About Conflicting Data, Confusing Results, and Some Recent Treatment Recommendations for the Management of Hypertension
Wendy Post, MD, MS; Marvin Moser, MD; Norman Kaplan, MD- J Clin Hypertens(2005) 7;10:606–611
|
|
|
|
Conflicting and Confusing Data From the Hypertension Treatment Trials: Whom and What Should You Believe?
Marvin Moser, MD; Thomas Giles, MD; Suzanne Oparil, MD- J Clin Hypertens(2005) 7;7:403–408
|
|
|
|
Secondary Hypertension–Whom and How Do You Study? What Type of Therapy Is Appropriate?
Marvin Moser, MD; Ronald Victor, MD; Joel Handler, MD- J Clin Hypertens(2005) 7;4:224–230
|
|
|
|
New-Onset Diabetes in Treated Hypertensive Patients–Is It Clinically Significant?
Marvin Moser, MD; James R. Sowers, MD; Suzanne Oparil, MD; Henry Black, MD- J Clin Hypertens(2005) 7;2:90–95
|
|
|
|
Hypertension in Children and Adolescents
Marvin Moser, MD; Thomas D. Giles, MD; Bonita Falkner, MD; Allan B. Schwartz, MD; Raymond R. Townsend, MD- J Clin Hypertens(2005) 7;1:24–30
|
|
|